SSY Group Ltd. logo

SSY Group Ltd. (LJUIF)

Market Closed
3 Jun, 20:00
OTC PINK OTC PINK
$
0. 40
0
0%
$
1.19B Market Cap
- P/E Ratio
0.1% Div Yield
700 Volume
- Eps
$ 0.4
Previous Close
Add Transaction
Day Range
0.4 0.7
Year Range
0.4 0.7
Want to track LJUIF and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

LJUIF closed yesterday higher at $0.4, an increase of 0% from Tuesday's close, completing a monthly decrease of 0% or $0. Over the past 12 months, LJUIF stock lost -42.3859%.
LJUIF pays dividends to its shareholders, with the most recent payment made on 21 hours ago. The next estimated payment will be in In 6 months on Dec 04, 2026 for a total of $0.00383.
The last earnings report, released on Mar 27, 2026, exceeded the consensus estimates by 0%. On average, the company has surpassed earnings expectations by 0%, based on the last three reports.
SSY Group Ltd. has completed 1 stock splits, with the recent split occurring on Jan 25, 2013.
The company's stock is traded on 2 different exchanges and in various currencies, with the primary listing on HKEX (HKD).

LJUIF Chart

People also search for

Dunelm Group plc Unsponsored ADR
$ 9.45
0%
Man Wah Holdings Ltd.
$ 9.59
-1.134%
Hisamitsu Pharmaceutical Co., Inc. Unsponsored ADR
$ 2.94
0%
Zeon Corporation - Unsponsored ADR
$ 9.73
0%
Telecom Italia S.p.A. Sponsored ADR
$ 8.59
+1.5366%

SSY Group Ltd. (LJUIF) FAQ

What is the stock price today?

The current price is $0.40.

On which exchange is it traded?

SSY Group Ltd. is listed on OTC PINK.

What is its stock symbol?

The ticker symbol is LJUIF.

Does it pay dividends? What is the current yield?

Yes, It pays dividends and the current yield is 0.1%.

What is its market cap?

As of today, the market cap is 1.19B.

Has SSY Group Ltd. ever had a stock split?

SSY Group Ltd. had 1 splits and the recent split was on Jan 25, 2013.

SSY Group Ltd. Profile

Specialty Retail Industry
Consumer Discretionary Sector
Jiguang Qu CEO
OTC PINK Exchange
KYG8406X1034 ISIN
HK Country
6,146 Employees
20 May 2026 Last Dividend
24 Sep 2012 Last Split
- IPO Date

Overview

SSY Group Limited operates as an investment holding company with a primary focus on the pharmaceutical sector. The organization is dedicated to the research, development, manufacturing, and distribution of a wide range of pharmaceutical products to hospitals and distributors both within the People's Republic of China and on an international level. The brand identity is represented under the "Shimen" brand name, emphasizing its commitment to quality and innovation in the healthcare industry. Originally established as Lijun International Pharmaceutical (Holding) Co., Ltd., it underwent a rebranding to SSY Group Limited in May 2015. Founded in 2004 and based in Wanchai, Hong Kong, SSY Group Limited serves as a subsidiary of China Pharmaceutical Co., Ltd., highlighting its significant role in the larger pharmaceutical domain.

Products and Services

SSY Group Limited offers an extensive portfolio of pharmaceutical products and services catered to meet the diverse needs of its clientele. These include:

  • Intravenous Infusion Solutions: The company produces various types of intravenous infusion solutions, such as non-PVC soft bags, upright soft bags, PP plastic bottles, and glass bottle infusion solutions, as well as ampoule injections. These products are essential in administering fluids and medications directly into a patient's vein, offering a range of administration options to cater to different clinical needs.
  • Small Volume Injections: These are used for administering medications via injection in smaller volumes, typically for medications that require precision in dosage and are intended for injections into specific sites.
  • Oral Preparations: This category includes medications intended for oral intake, comprising tablets, capsules, syrups, and more, designed for ease of use and effectiveness in treating various conditions.
  • Chinese Medicine Preparations: Reflecting its roots, SSY Group offers traditional Chinese medicine preparations, leveraging ancient wisdom with modern pharmaceutical processes to provide alternative medicinal options.
  • Biological Preparations: These are products derived from living organisms that are used in the diagnosis, prevention, or treatment of diseases. Biological preparations can include vaccines, blood components, allergenics, somatic cells, gene therapy, tissues, and recombinant therapeutic proteins.
  • Bulk Pharmaceutical Products and Medical Materials: The company also engages in the production and supply of bulk pharmaceutical ingredients and medical materials for further processing and manufacturing by other companies.
  • Pharmaceutical Technology Research, Development, and Consulting: Beyond manufacturing, SSY Group is involved in the pioneering research and development of pharmaceutical technologies, providing consulting services to foster innovation within the industry.
  • Logistics Services for Pharmaceutical Products: The company offers specialized logistics services tailored to the needs of the pharmaceutical sector, ensuring the safe and efficient distribution of medicines.
  • Food, Beverages, and Catering Business: Expanding its business scope, SSY Group engages in the food, beverages, and catering industry, applying its rigor and standards of excellence to this sector.
  • Production and Sale of Methylamine: The company has diversified its chemical production to include the manufacture and sale of methylamine, a compound used in various industrial and pharmaceutical applications.

Contact Information

Address: Central Plaza
Phone: 852 2688 0869